What does RIBI mean in NASDAQ SYMBOLS
Ribi ImmunoChem Research, Inc. (RIBI) is a biopharmaceutical company that specializes in developing and commercializing therapeutic vaccines and immunotherapies for the treatment of life-threatening infectious diseases and cancers. RIBI was founded in 1974 by Dr.Charles Ribi, an internationally recognized scientist and inventor who pioneered the development of antibodies as therapeutic agents to fight disease. The company has since grown to become one of the world's leading developers of innovative vaccine technologies and is committed to delivering treatments that are safe and effective for patients around the world.
RIBI meaning in NASDAQ Symbols in Business
RIBI mostly used in an acronym NASDAQ Symbols in Category Business that means Ribi ImmunoChem Research, Inc.
Shorthand: RIBI,
Full Form: Ribi ImmunoChem Research, Inc.
For more information of "Ribi ImmunoChem Research, Inc.", see the section below.
Essential Questions and Answers on Ribi ImmunoChem Research, Inc. in "BUSINESS»NASDAQ"
What does RIBI stand for?
RIBI stands for Ribi ImmunoChem Research, Inc..
What type of company is RIBI?
RIBI is a biopharmaceutical company that specializes in developing and commercializing therapeutic vaccines and immunotherapies for the treatment of life-threatening infectious diseases and cancers.
When was RIBI founded?
RIBI was founded in 1974 by Dr. Charles Ribi, an internationally recognized scientist and inventor.
What kind of products does RIBI specialize in?
RIBI specializes in developing and commercializing therapeutic vaccines and immunotherapies for the treatment of life-threatening infections diseases and cancers.
What is RIBI's commitment?
RIBI is committed to delivering treatments that are safe and effective for patients around the world.
Final Words:
RIBI ImmunoChem Research, Inc., or simply known as “RIBIâ€, is an award-winning biopharmaceutical company specializing in research, development, manufacturing, marketing, distribution, sales & services associated with deriving value from its antibody-based therapeutics platforms globally. Through its pioneering efforts over 4 decades ago when it was first established it has worked continuously on fulfilling its commitment to providing safe & effective treatments to patients everywhere.